Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

Summary

This is the first study in humans to evaluate the effectiveness of SJP-0132 in the treatment of dry eye disease. This study will evaluate the safety, tolerability, efficacy, and pharmacokinetics of single- and multiple-dose regimens of SJP-0132 in subjects with dry eye disease

Timeline

Start

2019-10-05

Primary completion

2020-03-03

Completion

2020-03-03

Drugs

Indications